| Model: | Ratio |
| Symbol | Title | Sector | Industry | M.Cap.[M] | Div Yield | Last Close | AvgVol 200d |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 963404 | 0.0054 | 1074.6801 | 4027945 |
| NVO | Novo Nordisk A/S | Healthcare | Drug Manufacturers - General | 226084 | 0.0339 | 50.88 | 14498552 |
| Entry Threshold: | 2.00 | Exit Threshold: | 0.00 | ||
| Max Duration: | 20 | Entry Mode: | Uptick | Reversals: | |
| MA Period: | 15 | MA Type: | DEMA | StdDev Period: | 15 |
| RSI Period: | 14 | RSI Threshold: | 0 | ||
| Margin Req. 1: | 50.0 | Margin Req. 2: | 50.0 | ||
| Version: | 5 | Model Version: | 2016.1 | Bid-Ask 0.01 / 0.01 | |
| Initial Capital: | 10000.00 | Final Equity: | 20543.33 |
| Total net P/L: | 10543.33 | Total ROI: | 105.43 % |
| CAGR: | 15.51 % | Max. DD: | 34.27 % |
| System Score: | 11.899 | Sharpe Ratio: | 1.715 |
| Start Date: | 2021-01-04 | End Date: | 2025-12-31 |
| Total days: | 1822 | ||
| Commissions: | 340.08 | Comm.% P/L | 3.12 % |
| Total Transactions: | 296 | Log. Linearity: | 91.536 % |
| Total | Long |
Short |
LLY | NVO | |
|---|---|---|---|---|---|
| Total Profit/Loss | 10883.41 | 11998.07 | -1114.66 | 2341.76 | 8541.65 |
| Total Profit | 29226.47 | 14046.89 | 15179.58 | 26538.25 | 28665.86 |
| Total Loss | 18343.06 | 2048.82 | 16294.24 | 24196.48 | 20124.22 |
| Profit Factor | 1.59 | 6.86 | 0.93 | 1.10 | 1.42 |
| Trades | 74 | 32 | 42 | 74 | 74 |
| Winning Trades | 56 | 27 | 29 | 40 | 50 |
| Losing Trades | 18 | 5 | 13 | 34 | 24 |
| % Profitable | 75.00 | 84.00 | 69.00 | 54.00 | 67.00 |
| Profit/Loss Per Trade % | 1.01 | 2.08 | 0.20 | 0.03 | 0.88 |
| Profit Per Trade % | 3.06 | 3.00 | 3.11 | 3.46 | 3.37 |
| Loss Per Trade % | 4.64 | 2.73 | 5.38 | 3.67 | 4.02 |
| Days In Trade | 629 | 262 | 367 | 629 | 629 |
| Days In Trade (Avg. Per Trade) | 8.50 | 8.19 | 8.74 | 8.50 | 8.50 |
| % Days In Trade | 34.52 | 14.38 | 20.14 | 34.52 | 34.52 |